Integra LifeSciences Holdings Corporation
IART
NASDAQ·Healthcare·Medical - Devices·Mkt cap $1.3B
$16.72
▲ +1.70%
P/E
-180.56
Mkt Cap
$1.3B
52-Wk Range
$8.70–$20.49
52-Week Range
$8.70 - $20.49
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 6.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Extensive product portfolio with approximately 40,000 instrument patterns and specialized surgical tools
- Strong market presence in high-barrier neurosurgery and specialty surgical markets
- Integrated distribution network across hospitals, surgery centers, and healthcare systems globally
- Proprietary regenerative technology and tissue repair solutions with clinical validation
- Established relationships with key opinion leaders and integrated health networks
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Rising demand for neurosurgical procedures driven by aging populations and neurological conditions
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Stable
-1.6% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying IART right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
JUL 29, 2026
Reported EPS of $0.56 vs $0.48 consensus (+16.6% surprise). Revenue of $418.8M vs $417.5M expected (+0.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+16.6%
Revenue trend · last 8Q
—
+11%
+4%
-1%
+6%
-2%
+2%
+1%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$380.8M
$442.6M
$382.7M
$415.6M
$402.1M
$434.9M
$391.9M
$418.8M
Margins · last 8Q
Gross
0.0%
Operating
4.6%
Profit
1.1%
Wall Street consensus
6 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
—
Latest: UBS · Jul 28, 2026
vs Industry
How IART stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related